Athersys completes $23 million public offering of Common Stock
Clients Athersys, Inc.
Jones Day represented Athersys, Inc., an international biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life, in connection with its public offering of 22,772,300 shares of Common Stock. William Blair & Company, L.L.C. acted as sole book-running manager and Needham & Company, LLC acted as lead manager for the offering.